J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF (NY:JGRO)

86.87 +0.19 (+0.22%)
Streaming Delayed Price Updated: 11:01 AM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,563
Open 87.01
Bid (Size) 86.80 (1)
Ask (Size) 86.81 (1)
Prev. Close 86.68
Today's Range 86.62 - 87.01
52wk Range 63.33 - 87.64
Shares Outstanding 758,000
Dividend Yield 0.10%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said. 
Via Stocktwits
Topics Artificial Intelligence
AbbVie Enters Licensing Agreement For IGI Therapeutics’ Experimental Oncology Drug: Retail Cheers
Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. 
Via Stocktwits
Topics Product Recall

Performance

YTD
+7.0%
+7.0%
1 Month
+4.9%
+4.9%
3 Month
+23.6%
+23.6%
6 Month
+3.9%
+3.9%
1 Year
+16.0%
+16.0%

More News

Read More
Intuitive Surgical Gets FDA Clearance For Advanced Energy Surgical Instrument: Retail Sentiment Improves
Via Stocktwits
Crumly Loads Up on 110,675 SDVY Shares in Q2 Filing
Via The Motley Fool
Topics ETFs Regulatory Compliance
Gilead, Global Fund Enter Agreement To Supply HIV Prevention Drug To Low & Lower-Middle-Income Countries
Via Stocktwits
Eli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side Effects
Via Stocktwits
Johnson & Johnson Submits Supplemental Drug Application To FDA For Schizophrenia Drug Caplyta
Via Stocktwits
Topics Government
AbbVie To Acquire Capstan Therapeutics For Up To $2.1 Billion To Boost Immunology Portfolio As Humira Sales Drop: Stock Gains In Morning Trade
Via Stocktwits
Topics Intellectual Property
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care
Via Stocktwits

Frequently Asked Questions

Is J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF publicly traded?
Yes, J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF is publicly traded.
What exchange does J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF trade on?
J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF trades on the New York Stock Exchange
What is the ticker symbol for J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF?
The ticker symbol for J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF is JGRO on the New York Stock Exchange
What is the current price of J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF?
The current price of J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF is 86.87
When was J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF last traded?
The last trade of J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF was at 07/23/25 11:01 AM ET
What is the market capitalization of J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF?
The market capitalization of J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF is 65.85M
How many shares of J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF are outstanding?
J.P. Morgan Exchange-Traded Fund Trust JPMorgan Active Growth ETF has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.